SG11202013236XA - Use of mitoxantrone liposome for treating non-hodgkin's lymphoma - Google Patents
Use of mitoxantrone liposome for treating non-hodgkin's lymphomaInfo
- Publication number
- SG11202013236XA SG11202013236XA SG11202013236XA SG11202013236XA SG11202013236XA SG 11202013236X A SG11202013236X A SG 11202013236XA SG 11202013236X A SG11202013236X A SG 11202013236XA SG 11202013236X A SG11202013236X A SG 11202013236XA SG 11202013236X A SG11202013236X A SG 11202013236XA
- Authority
- SG
- Singapore
- Prior art keywords
- hodgkin
- lymphoma
- treating non
- mitoxantrone liposome
- mitoxantrone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810756315.7A CN110711178A (en) | 2018-07-11 | 2018-07-11 | Application of mitoxantrone hydrochloride liposome in treating non-Hodgkin lymphoma |
| PCT/CN2019/095396 WO2020011189A1 (en) | 2018-07-11 | 2019-07-10 | Use of mitoxantrone liposome for treating non-hodgkin's lymphoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202013236XA true SG11202013236XA (en) | 2021-02-25 |
Family
ID=69143169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202013236XA SG11202013236XA (en) | 2018-07-11 | 2019-07-10 | Use of mitoxantrone liposome for treating non-hodgkin's lymphoma |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11583508B2 (en) |
| EP (1) | EP3821887B1 (en) |
| JP (1) | JP2021530489A (en) |
| KR (1) | KR20210031695A (en) |
| CN (2) | CN110711178A (en) |
| AU (1) | AU2019301101B2 (en) |
| BR (1) | BR112021000452A8 (en) |
| CA (1) | CA3105698A1 (en) |
| CU (1) | CU20210003A7 (en) |
| ES (1) | ES2980641T3 (en) |
| FI (1) | FI3821887T3 (en) |
| MX (1) | MX2020014107A (en) |
| PL (1) | PL3821887T3 (en) |
| PT (1) | PT3821887T (en) |
| SG (1) | SG11202013236XA (en) |
| WO (1) | WO2020011189A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220140805A (en) * | 2020-02-10 | 2022-10-18 | 씨에스피씨 종콰이 팔마씨우티컬 테크놀로지 (스자좡) 컴퍼니 리미티드 | Use of Mitosanthrone Hydrochloride Liposomes for the Treatment of Breast Cancer |
| CN115427020A (en) * | 2020-04-13 | 2022-12-02 | 石药集团中奇制药技术（石家庄）有限公司 | Application of mitoxantrone hydrochloride liposome |
| US20230293454A1 (en) * | 2020-08-07 | 2023-09-21 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd | Use of mitoxantrone hydrochloride liposome and pegaspargase |
| EP4205747A4 (en) * | 2020-08-27 | 2024-08-21 | Cspc Zhongqi Pharmaceutical Tech Shijiazhuang Co Ltd | Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone |
| CN115212168A (en) * | 2021-04-16 | 2022-10-21 | 石药集团中奇制药技术（石家庄）有限公司 | Application of mitoxantrone hydrochloride liposome |
| EP4349325A1 (en) * | 2021-05-28 | 2024-04-10 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Use of mitoxantrone hydrochloride liposome in preparation of drugs for treating advanced solid tumors |
| WO2023036161A1 (en) * | 2021-09-07 | 2023-03-16 | 石药集团中奇制药技术（石家庄）有限公司 | Use of mitoxantrone liposome, bortezomib and dexamethasone in treatment of multiple myeloma |
| CN117940164A (en) * | 2022-04-26 | 2024-04-26 | 石药集团中奇制药技术（石家庄）有限公司 | Application of mitoxantrone liposome combined with anti-angiogenesis targeting drug in treatment of ovarian cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0303719A2 (en) * | 2000-10-16 | 2004-03-01 | Neopharm, Inc. | Liposomal pharmaceutical composition of mitoxantrone and process for their preparation |
| US20040170677A1 (en) * | 2002-11-26 | 2004-09-02 | Ning Hu | Method of drug loading in liposomes by gradient |
| EP1537858A1 (en) * | 2003-12-04 | 2005-06-08 | Vectron Therapeutics AG | Drug delivery vehicles and uses thereof |
| EP1538164A1 (en) * | 2003-12-04 | 2005-06-08 | Vectron Therapeutics AG | RGD targeting moiety its production and use |
| JP4715133B2 (en) * | 2004-08-26 | 2011-07-06 | コニカミノルタエムジー株式会社 | Anti-tumor liposome preparation and production method thereof |
| CN101209243B (en) * | 2006-12-29 | 2010-12-08 | 石药集团中奇制药技术（石家庄）有限公司 | Liposome medicament and preparation thereof |
| WO2009020590A1 (en) * | 2007-08-07 | 2009-02-12 | Celgene Corporation | Methods for treating lymphomas in certain patient populations and screening patients for said therapy |
| CN103622909A (en) * | 2012-08-28 | 2014-03-12 | 吉林大学 | Cardiolipin-containing new liposome preparation, and its application in antitumor drugs |
| CA2883443C (en) * | 2012-08-30 | 2021-01-12 | James Sacchettini | Compositions and methods for drug-sensitization or inhibition of a cancer cell |
-
2018
- 2018-07-11 CN CN201810756315.7A patent/CN110711178A/en active Pending
-
2019
- 2019-07-10 CU CU2021000003A patent/CU20210003A7/en unknown
- 2019-07-10 KR KR1020217001296A patent/KR20210031695A/en not_active Application Discontinuation
- 2019-07-10 PT PT198333486T patent/PT3821887T/en unknown
- 2019-07-10 SG SG11202013236XA patent/SG11202013236XA/en unknown
- 2019-07-10 CN CN201980046225.1A patent/CN112384207B/en active Active
- 2019-07-10 BR BR112021000452A patent/BR112021000452A8/en unknown
- 2019-07-10 WO PCT/CN2019/095396 patent/WO2020011189A1/en unknown
- 2019-07-10 AU AU2019301101A patent/AU2019301101B2/en active Active
- 2019-07-10 FI FIEP19833348.6T patent/FI3821887T3/en active
- 2019-07-10 CA CA3105698A patent/CA3105698A1/en active Pending
- 2019-07-10 US US17/258,801 patent/US11583508B2/en active Active
- 2019-07-10 EP EP19833348.6A patent/EP3821887B1/en active Active
- 2019-07-10 ES ES19833348T patent/ES2980641T3/en active Active
- 2019-07-10 MX MX2020014107A patent/MX2020014107A/en unknown
- 2019-07-10 PL PL19833348.6T patent/PL3821887T3/en unknown
- 2019-07-10 JP JP2021500673A patent/JP2021530489A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN110711178A (en) | 2020-01-21 |
| CN112384207B (en) | 2024-02-06 |
| EP3821887A4 (en) | 2022-04-20 |
| CA3105698A1 (en) | 2020-01-16 |
| AU2019301101B2 (en) | 2023-10-05 |
| US11583508B2 (en) | 2023-02-21 |
| CU20210003A7 (en) | 2021-08-06 |
| CN112384207A (en) | 2021-02-19 |
| FI3821887T3 (en) | 2024-06-04 |
| MX2020014107A (en) | 2021-05-27 |
| BR112021000452A2 (en) | 2021-04-06 |
| KR20210031695A (en) | 2021-03-22 |
| PT3821887T (en) | 2024-06-12 |
| EP3821887A1 (en) | 2021-05-19 |
| AU2019301101A1 (en) | 2021-01-28 |
| ES2980641T3 (en) | 2024-10-02 |
| EP3821887B1 (en) | 2024-05-15 |
| PL3821887T3 (en) | 2024-07-08 |
| WO2020011189A1 (en) | 2020-01-16 |
| BR112021000452A8 (en) | 2021-11-03 |
| US20210267915A1 (en) | 2021-09-02 |
| JP2021530489A (en) | 2021-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202013236XA (en) | Use of mitoxantrone liposome for treating non-hodgkin's lymphoma | |
| ZA202006610B (en) | Compositions for the treatment of skin conditions | |
| LT3681500T (en) | Use of pilocarpine hydrochloride for the treatment of presbyopia | |
| ZA202007055B (en) | Compositions for the treatment of skin conditions | |
| EP3753435A4 (en) | Human hair fiber treatment agent | |
| IL276482A (en) | Compounds for the treatment of pain | |
| EP3753434A4 (en) | Human hair fiber treatment agent | |
| ZA202005222B (en) | Hair treatment compositions comprising reducing agents | |
| SG11202108852PA (en) | Hair treatment composition | |
| GB201914290D0 (en) | Composition for the care of human hair | |
| IL280721A (en) | Treatment of relapsed follicular lymphoma | |
| IL273909A (en) | Treatment of cd20-positive b-cell lymphoma with obituzumab | |
| IL289687A (en) | Compositions for the treatment of hair loss | |
| EP3813872A4 (en) | Compositions for the treatment of skin conditions | |
| PT3684477T (en) | Useful compositions for the cosmetic treatment of oily skin | |
| EP3744347A4 (en) | Composition for skin diseases treatment use | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| IL289336A (en) | Compounds and methods of use thereof as antibacterial agents | |
| IL286533A (en) | Compounds for use in the treatment of adcy5-related dyskinesia | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| GB201908076D0 (en) | Skin treatment composition | |
| IL276228A (en) | Compounds and compositions for the treatment of pain | |
| EP3604310A4 (en) | Cdc-7-inhibitor compounds and use thereof for the treatment of neurological conditions | |
| PL3975982T3 (en) | Increasing the stability of agents for treating keratin material | |
| KR102389953B9 (en) | Skin treatment maskpack |